NEPTUNE WELLNESS SOLUTIONS INC. Research and Development Expense
NEPTUNE WELLNESS SOLUTIONS INC. reported Research and Development Expense of $727 for the 3-month period ending 2023-12-31, per its 10-Q filed 2024-02-16.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2024-02-16
- NEPTUNE WELLNESS SOLUTIONS INC. research and development expense for the quarter ending 2023-12-31 was $727.00, a 97.48% decline year-over-year.
- NEPTUNE WELLNESS SOLUTIONS INC. research and development expense for the quarter ending 2023-09-30 was $24.68K, a 88.11% decline year-over-year.
- NEPTUNE WELLNESS SOLUTIONS INC. research and development expense for the quarter ending 2023-06-30 was $21.86K, a 89.82% decline year-over-year.
- NEPTUNE WELLNESS SOLUTIONS INC. research and development expense for the quarter ending 2023-03-31 was $33.10K, a 85.46% decline year-over-year.
- NEPTUNE WELLNESS SOLUTIONS INC. research and development expense for fiscal 2023 was $484.22K, a 44.98% decline from fiscal 2022.
- NEPTUNE WELLNESS SOLUTIONS INC. research and development expense for fiscal 2022 was $880.15K, a 54.21% decline from fiscal 2021.
- NEPTUNE WELLNESS SOLUTIONS INC. research and development expense for fiscal 2021 was $1.92M.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2023-12-31 | $727.00 10-Q · filed 2024-02-16 | $25.40K derived: sum of 2 quarters · filed 2024-02-16 | $47.27K 10-Q · filed 2024-02-16 | $80.37K derived: sum of 4 quarters · filed 2024-02-16 |
| 2023-09-30 | $24.68K 10-Q · filed 2023-11-14 | $46.54K 10-Q · filed 2023-11-14 | $79.64K derived: sum of 3 quarters · filed 2023-11-14 | $108.48K derived: sum of 4 quarters · filed 2024-02-16 |
| 2023-06-30 | $21.86K 10-Q/A · filed 2023-09-06 | $54.97K derived: sum of 2 quarters · filed 2023-09-06 | $83.80K derived: sum of 3 quarters · filed 2024-02-16 | $291.40K derived: sum of 4 quarters · filed 2024-02-16 |
| 2023-03-31 | $33.10K derived: 10-K 12 month − 10-Q 9 month · filed 2023-07-17 | $61.94K derived: sum of 2 quarters · filed 2024-02-16 | $269.54K derived: sum of 3 quarters · filed 2024-02-16 | $484.22K 10-K · filed 2023-07-17 |
| 2022-12-31 | $28.84K 10-Q · filed 2024-02-16 | $236.43K derived: sum of 2 quarters · filed 2024-02-16 | $451.12K 10-Q · filed 2024-02-16 | $678.85K derived: sum of 4 quarters · filed 2024-02-16 |
| 2022-09-30 | $207.60K 10-Q · filed 2023-11-14 | $422.29K 10-Q · filed 2023-11-14 | $650.01K derived: sum of 3 quarters · filed 2023-11-14 | $951.66K derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $214.69K 10-Q/A · filed 2023-09-06 | $442.42K derived: sum of 2 quarters · filed 2023-09-06 | $744.06K derived: sum of 3 quarters · filed 2023-09-06 | $835.17K derived: sum of 4 quarters · filed 2023-09-06 |
| 2022-03-31 | $227.73K derived: 10-K 12 month − 10-Q 9 month · filed 2023-07-17 | $529.38K derived: sum of 2 quarters · filed 2023-07-17 | $620.49K derived: sum of 3 quarters · filed 2023-07-17 | $880.15K 10-K · filed 2023-07-17 |
| 2021-12-31 | $301.64K 10-Q · filed 2023-03-30 | $392.75K derived: sum of 2 quarters · filed 2023-03-30 | $652.42K 10-Q · filed 2023-03-30 | |
| 2021-09-30 | $91.11K 10-Q · filed 2022-12-20 | $350.78K 10-Q · filed 2022-12-20 | ||
| 2021-06-30 | $259.67K 10-Q · filed 2022-08-15 | |||
| 2021-03-31 | $1.92M 10-K · filed 2022-07-08 |